Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System.

in vitro and in vivo methods neurological disorders nuclear factor kappa B transcription factor

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
28 05 2021
Historique:
received: 13 03 2021
revised: 18 05 2021
accepted: 20 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 11 2021
Statut: epublish

Résumé

The transcription factor nuclear factor kappa B (NF-κB) is highly expressed in almost all types of cells. NF-κB is involved in many complex biological processes, in particular in immunity. The activation of the NF-κB signaling pathways is also associated with cancer, diabetes, neurological disorders and even memory. Hence, NF-κB is a central factor for understanding not only fundamental biological presence but also pathogenesis, and has been the subject of intense study in these contexts. Under healthy physiological conditions, the NF-κB pathway promotes synapse growth and synaptic plasticity in neurons, while in glia, NF-κB signaling can promote pro-inflammatory responses to injury. In addition, NF-κB promotes the maintenance and maturation of B cells regulating gene expression in a majority of diverse signaling pathways. Given this, the protein plays a predominant role in activating the mammalian immune system, where NF-κB-regulated gene expression targets processes of inflammation and host defense. Thus, an understanding of the methodological issues around its detection for localization, quantification, and mechanistic insights should have a broad interest across the molecular neuroscience community. In this review, we summarize the available methods for the proper detection and analysis of NF-κB among various brain tissues, cell types, and subcellular compartments, using both qualitative and quantitative methods. We also summarize the flexibility and performance of these experimental methods for the detection of the protein, accurate quantification in different samples, and the experimental challenges in this regard, as well as suggestions to overcome common challenges.

Identifiants

pubmed: 34071243
pii: cells10061335
doi: 10.3390/cells10061335
pmc: PMC8228352
pii:
doi:

Substances chimiques

NF-kappa B 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : PJT-162144
Pays : Canada
Organisme : St. Boniface Hospital Foundation
ID : 1403-3131

Références

Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2647-52
pubmed: 19196984
Front Neurol. 2015 May 20;6:98
pubmed: 26042083
J Neurosci. 2001 Jul 1;21(13):4668-77
pubmed: 11425894
Cell Signal. 2010 Sep;22(9):1282-90
pubmed: 20363318
Cell Death Differ. 2006 May;13(5):773-84
pubmed: 16410802
Synapse. 2000 Feb;35(2):151-9
pubmed: 10611641
Mol Cell. 2002 Mar;9(3):625-36
pubmed: 11931769
Int J Mol Sci. 2017 Jan 18;18(1):
pubmed: 28106772
J Neurochem. 2019 Jul;150(2):113-137
pubmed: 30802950
Genes Dev. 2012 Feb 1;26(3):203-34
pubmed: 22302935
J Biomol Screen. 2012 Aug;17(7):921-32
pubmed: 22498909
Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a000158
pubmed: 20300203
Cell Commun Signal. 2013 Mar 21;11(1):19
pubmed: 23517552
Biomark Insights. 2010 Feb 09;5:9-20
pubmed: 20212918
Dialogues Clin Neurosci. 2009;11(2):111-28
pubmed: 19585947
Nat Med. 2005 Dec;11(12):1322-9
pubmed: 16286924
J Biol Chem. 2005 Mar 18;280(11):9957-62
pubmed: 15642694
Aging Dis. 2021 Apr 1;12(2):441-465
pubmed: 33815876
Mol Cell. 2009 Jun 12;34(5):591-602
pubmed: 19524538
Mol Cell Oncol. 2014 Dec 23;1(3):e963478
pubmed: 27308348
PLoS One. 2018 Jun 28;13(6):e0199966
pubmed: 29953522
Mol Cell Biol. 2008 May;28(10):3139-50
pubmed: 18299388
Trends Mol Med. 2002 Jun;8(6):257-60
pubmed: 12067606
J Pharmacol Toxicol Methods. 2011 Jan-Feb;63(1):7-14
pubmed: 20348003
Oncogene. 2006 Oct 30;25(51):6680-4
pubmed: 17072321
Nature. 2013 May 9;497(7448):211-6
pubmed: 23636330
BMC Mol Biol. 2007 Jul 31;8:64
pubmed: 17663801
Methods Mol Biol. 2012;809:85-104
pubmed: 22113270
Int J Cancer. 2010 Jul 15;127(2):404-11
pubmed: 19924814
Mol Cell Biol. 1994 Jun;14(6):3981-92
pubmed: 8196637
Expert Rev Proteomics. 2014 Oct;11(5):549-60
pubmed: 25059473
Mol Diagn. 2003;7(3-4):187-94
pubmed: 15068390
J Immunol Methods. 2008 Jan 1;329(1-2):194-200
pubmed: 18036607
Sci Rep. 2016 Nov 17;6:37116
pubmed: 27853238
Learn Mem. 2008 Jul 11;15(7):539-49
pubmed: 18626097
PLoS One. 2013;8(3):e60290
pubmed: 23536907
Biomed Res Int. 2014;2014:612798
pubmed: 24678511
N Am J Med Sci. 2012 Sep;4(9):429-34
pubmed: 23050259
Scand J Med Sci Sports. 2017 Jan;27(1):4-25
pubmed: 27263489
Cell Res. 2011 Jan;21(1):71-85
pubmed: 21173796
Mol Neurodegener. 2011 Jun 10;6:42
pubmed: 21663635
Aging Dis. 2011 Dec;2(6):449-65
pubmed: 22396894
BMC Immunol. 2014 Dec 20;15:586
pubmed: 25527077
Methods. 2014 Nov;70(1):46-58
pubmed: 25242720
Neuroscience. 2017 Oct 11;361:81-92
pubmed: 28802916
FASEB J. 2019 Mar;33(3):4188-4202
pubmed: 30526044
FEBS Lett. 2016 Sep;590(17):2813-26
pubmed: 27427408
Cytometry A. 2011 Jun;79(6):461-9
pubmed: 21520400
J Infect Dis. 2000 Nov;182(5):1437-45
pubmed: 11023466
Cell. 2017 Jan 12;168(1-2):37-57
pubmed: 28086098
Methods Mol Biol. 2015;1280:395-409
pubmed: 25736763
J Cancer Metastasis Treat. 2017;3:45-59
pubmed: 28626800
Anat Rec (Hoboken). 2012 Mar;295(3):369-71
pubmed: 22302360
Cold Spring Harb Perspect Biol. 2009 Sep;1(3):a001271
pubmed: 20066105
Biotechniques. 2011 Oct;51(4):267-9
pubmed: 21988693
Mitochondrion. 2021 Mar;57:63-75
pubmed: 33378713
Brain Res. 2004 Apr 9;1004(1-2):91-7
pubmed: 15033423
Front Mol Neurosci. 2016 Nov 09;9:118
pubmed: 27881951
J Histochem Cytochem. 2014 Feb;62(2):157-61
pubmed: 24255050
Trends Neurosci. 2005 Jan;28(1):37-43
pubmed: 15626495
Signal Transduct Target Ther. 2020 May 1;5(1):60
pubmed: 32355263
Am J Cancer Res. 2011;1(4):446-59
pubmed: 21984965
BMC Mol Biol. 2008 May 06;9:46
pubmed: 18460208
Physiol Rev. 2009 Jan;89(1):121-45
pubmed: 19126756
BMC Bioinformatics. 2011 Jul 05;12:276
pubmed: 21729324
Cell Death Differ. 2006 May;13(5):852-60
pubmed: 16397579
Nat Commun. 2015 May 07;6:7068
pubmed: 25946967
PLoS One. 2012;7(12):e52337
pubmed: 23300644
J Neuroinflammation. 2016 Sep 06;13(1):237
pubmed: 27596278
Exp Ther Med. 2018 Sep;16(3):2756-2762
pubmed: 30210617
Nat Cell Biol. 2007 Sep;9(9):1081-8
pubmed: 17704767
Mediators Inflamm. 2018 Apr 26;2018:3020675
pubmed: 29853786
J Biol Chem. 1991 Jan 5;266(1):252-60
pubmed: 1985897
PLoS One. 2013 Aug 09;8(8):e70773
pubmed: 23951005
Biotechniques. 2004 Dec;37(6):961-9
pubmed: 15597545
Int J Mol Sci. 2011;12(9):5461-70
pubmed: 22016602
Immunol Rev. 2006 Apr;210:171-86
pubmed: 16623771
Sci Rep. 2018 Apr 16;8(1):5990
pubmed: 29662072
Oncogene. 2006 Oct 30;25(51):6717-30
pubmed: 17072324
Adv Physiol Educ. 2005 Sep;29(3):151-9
pubmed: 16109794
J Immunol. 2002 Feb 1;168(3):1441-6
pubmed: 11801687
J Vis Exp. 2014 Dec 03;(94):
pubmed: 25548934
J Biol Chem. 2002 Mar 29;277(13):10842-51
pubmed: 11801607
Ann N Y Acad Sci. 2005 Nov;1056:218-33
pubmed: 16387690
J Biol Chem. 2003 Jan 24;278(4):2758-66
pubmed: 12419806
Neuro Oncol. 2016 Mar;18(3):329-39
pubmed: 26534766
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2669-74
pubmed: 20133768
Sci Rep. 2020 May 7;10(1):7734
pubmed: 32382091
J Immunol Methods. 1998 Jul 1;216(1-2):49-67
pubmed: 9760215
Front Mol Neurosci. 2015 Nov 18;8:70
pubmed: 26635523
Mol Imaging. 2009 Sep-Oct;8(5):278-90
pubmed: 19796605
Glia. 2019 Aug;67(8):1449-1461
pubmed: 30957303
J Immunol Methods. 2006 Apr 20;311(1-2):117-29
pubmed: 16563425
J Immunol Methods. 2015 Aug;423:3-11
pubmed: 25862606
Front Cell Dev Biol. 2019 Aug 07;7:154
pubmed: 31448275
Neuroscience. 2013 Oct 10;250:282-299
pubmed: 23872390
Cells. 2016 Mar 18;5(1):
pubmed: 26999213
RNA. 2011 Jan;17(1):14-20
pubmed: 21098142
J Biol Chem. 2000 Sep 22;275(38):29840-6
pubmed: 10882738
Nature. 1998 Jan 22;391(6665):410-3
pubmed: 9450761
MethodsX. 2015 Nov 07;2:440-5
pubmed: 26740924
Neuropharmacology. 2003 Mar;44(3):374-80
pubmed: 12604095
Genes (Basel). 2018 Jan 09;9(1):
pubmed: 29315242
Sci Rep. 2015 Jul 03;5:11842
pubmed: 26138224
Biochemistry. 2010 Mar 2;49(8):1560-7
pubmed: 20055496
Nat Commun. 2016 May 25;7:11686
pubmed: 27221592
Clin Lab. 2013;59(7-8):827-30
pubmed: 24133912
BMC Res Notes. 2010 Nov 10;3:294
pubmed: 21067583
PLoS One. 2014 Mar 04;9(3):e90104
pubmed: 24595030
Mech Dev. 1993 Oct;43(2-3):135-47
pubmed: 8297787
Nat Protoc. 2007;2(8):1849-61
pubmed: 17703195
Neuroscience. 2015 Apr 16;291:70-80
pubmed: 25659345
Anal Biochem. 2014 Nov 15;465:70-2
pubmed: 25004462
Annu Rev Immunol. 2000;18:621-63
pubmed: 10837071
Annu Rev Biophys. 2013;42:443-68
pubmed: 23495970
Cell Mol Life Sci. 2002 Nov;59(11):1833-50
pubmed: 12530517
Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034
pubmed: 20066092
Methods Mol Biol. 2018;1714:67-78
pubmed: 29177856
FASEB J. 2018 Apr;32(4):1916-1932
pubmed: 29187362
PLoS One. 2013 Nov 11;8(11):e78695
pubmed: 24244341
Front Immunol. 2017 Dec 11;8:1805
pubmed: 29312321
Curr Genomics. 2007 Jun;8(4):234-51
pubmed: 18645596
Cell. 1986 Aug 29;46(5):705-16
pubmed: 3091258
J Biochem Biophys Methods. 2005 Oct 31;65(1):20-9
pubmed: 16198424
Nucleic Acids Res. 2001 Feb 15;29(4):E21
pubmed: 11160941
Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):4878-83
pubmed: 20194791
Immunity. 1995 Sep;3(3):263-72
pubmed: 7552992
Sci Rep. 2018 Jan 9;8(1):199
pubmed: 29317736
Mol Neurodegener. 2013 Oct 12;8:40
pubmed: 24119288
Nat Rev Immunol. 2017 Sep;17(9):545-558
pubmed: 28580957
J Pathol Transl Med. 2016 Nov;50(6):411-418
pubmed: 27809448
J Inflamm Res. 2018 Oct 30;11:407-419
pubmed: 30464573
EMBO J. 2004 Oct 27;23(21):4202-10
pubmed: 15470505
Cell Death Differ. 2001 Jun;8(6):621-30
pubmed: 11536013
J Clin Invest. 2001 Feb;107(3):247-54
pubmed: 11160145
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2642-7
pubmed: 9122249
Nat Neurosci. 2003 Oct;6(10):1072-8
pubmed: 12947408

Auteurs

Marina Mostafizar (M)

Division of Neurodegenerative Disorders, St. Boniface Hospital Research, Winnipeg, MB R2H 2A6, Canada.

Claudia Cortes-Pérez (C)

Division of Neurodegenerative Disorders, St. Boniface Hospital Research, Winnipeg, MB R2H 2A6, Canada.

Wanda Snow (W)

Division of Neurodegenerative Disorders, St. Boniface Hospital Research, Winnipeg, MB R2H 2A6, Canada.

Jelena Djordjevic (J)

Division of Neurodegenerative Disorders, St. Boniface Hospital Research, Winnipeg, MB R2H 2A6, Canada.

Aida Adlimoghaddam (A)

Division of Neurodegenerative Disorders, St. Boniface Hospital Research, Winnipeg, MB R2H 2A6, Canada.

Benedict C Albensi (BC)

Division of Neurodegenerative Disorders, St. Boniface Hospital Research, Winnipeg, MB R2H 2A6, Canada.
Department of Pharmacology and Therapeutics, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R2H 2A6, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH